Biotechnology markets include the tools, consumables, services and intellectual property necessary for life sciences and applied medical research. The products of such research include biopharmaceuticals, vaccines, and other biologics. Emerging markets like that of mass spectrometry used in clinical testing applications highlight technological advances that urge more companies to make deals in the field of biotechnology. As the industry grows, companies will develop and integrate automated platforms and diagnostic kits that greatly increase convenience and reliability. This efficiency-mindedness had permeated the past decade in the biotechnology field, as the pace and breadth of translational or biomedical research has created multi-billion dollar markets for research tools and services as well as for the discovered and subsequently marketed biologics. In the future, companies hope to see convenient clinical diagnostic applications eventually coming into multiple areas of the clinical lab.
The study of individual cells has long been an important part of biological research.? Historically this has been a very manual process; some automated technologies are available.? The need for microscopy and other traditional methods has remained, as new methods have also arrived, all of which have been gradually improved.? The ability to amplify DNA […]
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of […]
Download Brochure The most comprehensive database of installed clinical diagnostic equipment in the U.S. The Kalorama Information MasterFile contains detailed information on more than 5,300 hospitals and testing facilities and over 42,000 clinical diagnostic instruments across 12 modalities: Blood Gas Analyzers Chemistry Coagulation Hematology Immunoassay Integrated Chem/Immuno Mass Spectrometry Microbiology AST ID Microbiology Blood Culture […]
CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the […]
Outsourcing drug discovery is the beginning phase of the drug development process. Through outsourcing portions of their drug discovery programs, many pharmaceutical and biotechnology companies have found an effective cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug […]
What is the Size of the Cell and Gene Therapy Market? According to the latest report on the cell and gene therapy market from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3,866 million And most of the market is for the treatment of cancer. Dermatological, Cardiovascular […]
The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine […]
For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most […]
Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD). NASH is characterized by inflammation in the liver and liver cell damage, which can lead to scarring of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks […]
CAR-T cell therapy is a form of immunotherapy that utilizes the body’s own T cells to target and destroy cancer cells. This therapy is a personalized form of treatment, meaning that each patient receives T cells that are geared specifically toward his or her cancer diagnosis. T-cell therapy works by removing existing T cells from […]
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.